Article
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Cancer cell - 13 Nov 2017
Hurst Carolyn D, Alder Olivia, Platt Fiona M, Droop Alastair, Stead Lucy F, Burns Julie E, Burghel George J, Jain Sunjay, Klimczak Leszek J, Lindsay Helen, Roulson Jo-An, Taylor Claire F, Thygesen Helene, Cameron Angus J, Ridley Anne J, Mott Helen R, Gordenin Dmitry A, Knowles Margaret A
Abstract excerpt
Bladder cancer incurs a higher lifetime treatment cost than other cancers due to frequent recurrence of non-invasive disease. Improved prognostic biomarkers and localized therapy are needed for this large patient group. We defined two major genomic subtypes of primary stage Ta tumors. One of these was characterized by loss of 9q including TSC1, increased KI67 labeling index, upregulated glycolysis, DNA repair,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.